# LUPKYNIS
> **NDA213716** · New Drug Application · Sponsor: AURINIA · Approved 2021-01-22
## Drug
- **FDA Application Number:** NDA213716
- **Application type:** New Drug Application
- **Brand name:** LUPKYNIS
- **Generic name:** VOCLOSPORIN
- **Active ingredients:** VOCLOSPORIN
- **Dosage form:** CAPSULE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** AURINIA
- **Manufacturer:** Aurinia Pharma U.S., Inc.
- **First approval:** 2021-01-22
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213716)
---
*MORVS · CC0 1.0*